Encapsulation of Ibuprofen in CD-MOF and Related Bioavailability Studies

被引:178
作者
Hartlieb, Karel J. [1 ]
Ferris, Daniel P. [1 ]
Holcroft, James M. [1 ]
Kandela, Irawati [2 ]
Stern, Charlotte L. [1 ]
Nassar, Majed S. [3 ]
Botros, Youssry Y. [4 ]
Stoddart, J. Fraser [1 ]
机构
[1] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA
[2] Northwestern Univ, Chem Life Proc Inst, 2145 Sheridan Rd, Evanston, IL 60208 USA
[3] King Abdul Aziz City Sci & Technol KACST, Joint Ctr Excellence Integrated Nanosyst JCIN, POB 6068, Riyadh 11442, Saudi Arabia
[4] PanaceaNano Inc, 2265 East Foothill Blvd, Pasadena, CA 91107 USA
关键词
cyclodextrin; drug delivery; ibuprofen; metal-organic framework; METAL-ORGANIC-FRAMEWORK; ORAL-DRUG DELIVERY; CARBON-DIOXIDE; CYCLODEXTRINS; NANOPARTICLES; FORMULATIONS; TECHNOLOGIES; ADSORPTION; CATALYSTS; POLYMERS;
D O I
10.1021/acs.molpharmaceut.7b00168
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Although ibuprofen is one of the most widely used nonsteroidal anti-inflammatory drugs (NSAIDs), it exhibits poor solubility in aqueous and physiological environments as a free acid. In order to improve its oral bioavailability and rate of uptake, extensive research into the development of new formulations of ibuprofen has been undertaken, including the use of excipients as well as ibuprofen salts, such as ibuprofen lysinate and ibuprofen, sodium salt. The ultimate goals of these studies are to reduce the time required for maximum uptake of ibuprofen, as this period of time is directly proportional to the rate of onset of analgesic/anti-inflammatory effects, and to increase the half-life of the drug within the body; that is, the duration of action of the effects of the drug. Herein, we present a pharmaceutical cocrystal of ibuprofen and the biocompatible metal-organic framework called CD-MOF. This metal-organic framework (MOF) is based upon gamma-cyclodextrin (gamma-CD) tori that are coordinated to alkali metal cations (e.g., K+ ions) on both their primary and secondary faces in an alternating manner to form a porous framework built up from (gamma-CD)(6) cubes. We show that ibuprofen can be incorporated within CD-MOF-1 either by (i) a crystallization process using the potassium salt of ibuprofen as the alkali cation source for production of the MOF or by (ii) absorption and deprotonation of the free-acid, leading to an uptake of 23-26 wt % of ibuprofen within the CD-MOF. In vitro viability studies revealed that the CD-MOF is inherently not affecting the viability of the cells with no IC50 value determined up to a concentration of 100 mu M. Bioavailability investigations were conducted on mice, and the ibuprofen/CD-MOF pharmaceutical cocrystal was compared to control samples of the potassium salt of ibuprofen in the presence and absence of gamma-CD. From these animal studies, we observed that the ibuprofen/CD-MOF-1 cocrystal exhibits the same rapid uptake of ibuprofen as the ibuprofen potassium salt control sample with a peak plasma concentration observed within 20 min, and the cocrystal has the added benefit of a 100% longer half-life in blood plasma samples and is intrinsically less hygroscopic than the pure salt form.
引用
收藏
页码:1831 / 1839
页数:9
相关论文
共 59 条
  • [1] PHARMACOLOGICAL DIFFERENCES BETWEEN OPTICAL ISOMERS OF IBUPROFEN - EVIDENCE FOR METABOLIC INVERSION OF (-)-ISOMER
    ADAMS, SS
    BRESLOFF, P
    MASON, CG
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (03) : 256 - 257
  • [2] Screening of bio-compatible metal-organic frameworks as potential drug carriers using Monte Carlo simulations
    Bernini, Maria C.
    Fairen-Jimenez, David
    Pasinetti, Marcelo
    Ramirez-Pastor, Antonio J.
    Snurr, Randall Q.
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2014, 2 (07) : 766 - 774
  • [3] Fast dissolving cyclodextrin complex of piroxicam in solid dispersion Part I: Influence of β-CD and HPβ-CD on the dissolution rate of piroxicam
    Bouchal, F.
    Skiba, M.
    Chaffai, N.
    Hallouard, F.
    Fatmi, S.
    Lahiani-Skiba, M.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 478 (02) : 625 - 632
  • [4] Cyclodextrins as pharmaccutical solubilizers
    Brewster, Marcus E.
    Loftsson, Thorsteinn
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) : 645 - 666
  • [5] Enantioselective adsorption of ibuprofen and lysine in metal-organic frameworks
    Bueno-Perez, Rocio
    Martin-Calvo, Ana
    Gomez-Alvarez, Paula
    Gutierrez-Sevillano, Juan J.
    Merkling, Patrick J.
    Vlugt, Thijs J. H.
    van Erp, Titus S.
    Dubbeldam, David
    Calero, Sofia
    [J]. CHEMICAL COMMUNICATIONS, 2014, 50 (74) : 10849 - 10852
  • [6] A Redox-Active Bistable Molecular Switch Mounted inside a Metal-Organic Framework
    Chen, Qishui
    Sun, Junling
    Li, Peng
    Hod, Idan
    Moghadam, Peyman Z.
    Kean, Zachary S.
    Snurr, Randall Q.
    Hupp, Joseph T.
    Farha, Omar K.
    Stoddart, J. Fraser
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (43) : 14242 - 14245
  • [7] Integrated Nanozymes with Nanoscale Proximity for in Vivo Neurochemical Monitoring in Living Brains
    Cheng, Hanjun
    Zhang, Lei
    He, Jian
    Guo, Wenjing
    Zhou, Zhengyang
    Zhang, Xuejin
    Nie, Shuming
    Wei, Hui
    [J]. ANALYTICAL CHEMISTRY, 2016, 88 (10) : 5489 - 5497
  • [8] Metal-organic frameworks: versatile heterogeneous catalysts for efficient catalytic organic transformations
    Chughtai, Adeel H.
    Ahmad, Nazir
    Younus, Hussein A.
    Laypkov, A.
    Verpoort, Francis
    [J]. CHEMICAL SOCIETY REVIEWS, 2015, 44 (19) : 6804 - 6849
  • [9] Rationalization of the entrapping of bioactive molecules into a series of functionalized porous zirconium terephthalate MOFs
    Cunha, D.
    Gaudin, C.
    Colinet, I.
    Horcajada, P.
    Maurin, G.
    Serre, C.
    [J]. JOURNAL OF MATERIALS CHEMISTRY B, 2013, 1 (08) : 1101 - 1108
  • [10] Dewland Peter M, 2009, BMC Clin Pharmacol, V9, P19, DOI 10.1186/1472-6904-9-19